NxStage Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 84   

Articles published

NXTM 17.34 -0.29 (-1.64%)
price chart
NxStage Medical Unveils Streamline Express Dialyzer
The company's DICEA dialyzers provides significant treatment flexibility. Polysulfone dialyzer by Fresenius Medical has also been there in the market for quite some time. Hence it remains to be seen if the new offering from Nxstage can actually beat ...
NxStage Medical Unveils Streamline Express Dialyzer - Analyst Blog  Nasdaq
Related articles »  
Why NxStage Medical Inc. Stock Surged Higher
Why it's happening: For the quarter, NxStage Medical reported a 13% increase in revenue to a record $75.3 million, which happened to be higher than the prior guidance issued by the company of $71 million-$72.5 million issued during its second-quarter ...
NxStage Announces Fourth Quarter 2014 Investor Conference Schedule  PR Newswire (press release)
NxStage Medical Inc.: NxStage Reports Record Third Quarter 2014 Financial ...  The Wall Street Transcript
Related articles »  
Update: NxStage Medical Q3 2014 Earnings (NXTM)
NxStage Medical's (NASDAQ:NXTM) third-quarter 2014 revenue grew 13% to a record $75.3 million, compared to $66.9 million in the year-ago period.
NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood ...  PR Newswire (press release)
Insider Selling: Joseph E. Turk, Jr. Sells 29560 Shares of NxStage Medical ...  WKRB News
Related articles »  
Why NxStage Medical Inc. Shares Slumped
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Related articles »  
Nxstage Medical Inc. (NXTM) Hits New 52-week High During November 18 ...
Nxstage Medical Inc. is also a component of the Russell 2000 Index, which is an invaluable tool for any small-cap investor.
Related articles »  
NxStage Medical, Inc. (NXTM) news: NxStage Medical's CEO Discusses Q4 ...
Good day, ladies and gentlemen, and welcome to the NxStage Medical's Fourth Quarter Fiscal 2013 Financial Results Conference Call.
Related articles »  
Commit To Purchase NxStage Medical At $12.50, Earn 14.1% Annualized Using ...
Investors considering a purchase of NxStage Medical Inc (Symbol: NXTM) stock, but cautious about paying the going market price of $13.65/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Related articles »  
News Roundup- Boston Scientific Corporation (NYSE:BSX), NxStage Medical ...
NxStage Medical, Inc. (NASDAQ:NXTM) currently posted third quarter revenue that surpasses the top end of its leadership range.
Related articles »  
Equities in Focus - Supernus Pharmaceuticals Inc (NASDAQ:SUPN), NxStage ...
NxStage Medical, Inc. (NASDAQ:NXTM) says the first matched cohort study of its kind shows patients using products like the company's frequent home hemodialysis (HHD) have a 16% lower risk of death, 8% lower risk of hospitalization, and 38% lower risk ...
Related articles »  
Insider Selling: NxStage Medical President Unloads 24761 Shares of Stock ...
NxStage Medical (NASDAQ:NXTM) last announced its earnings results on Thursday, November 6th. The company reported ($0.11) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.13) by $0.02.
Insider Selling: NxStage Medical CAO Unloads 11056 Shares of Stock (NXTM)  Mideast Time
Related articles »